CliffBio
small molecule

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameEMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
Active ingredientEMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Strength120MG;EQ 15MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2024
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.